UNITEDHEALTH GROUP INC

UnitedHealth Group operates in the health care and well-being industry, with a mission to help people live healthier lives and help make the health system work better for everyone. The company's two distinct, yet complementary businesses — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences. The filing notes that in the United States, health care spending has grown consistently for many years and accounted for 19% of gross domestic product (GDP) in 2025. The company expects overall spending on health care to continue to grow in the future, due to inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends in the population and national interest in health and well-being.

The filing names competitors including organizations ranging from startups to highly sophisticated Fortune 50 global enterprises, for-profit and non-profit companies, and private and government-sponsored entities. The company competes fundamentally on the quality and value it provides, which can include elements such as product and service innovation, use of technology, consumer and provider engagement and satisfaction, and sales, marketing and pricing. The filing notes that the company's competitive position may be adversely affected by significant merger and acquisition activity in the industries in which it operates, among both competitors and suppliers.

The company generates revenue through two distinct, yet complementary businesses: Optum and UnitedHealthcare. Optum is an information and technology-enabled health services business serving the broad health care marketplace, including those who need care, those who provide care, those who pay for care, and those who innovate for care. UnitedHealthcare offers a full range of health benefits, designed to simplify the health care experience and make it more affordable for consumers to access high-quality care. Premium revenues from risk-based products constitute nearly 80% of total consolidated revenues. The company also generates revenue from products and services, with product revenues including the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments, and services revenue including fees from administrative services for self-funded customers and software and information products.

UnitedHealthcare offers a full range of health benefits through three major market segments. UnitedHealthcare Employer & Individual serves consumers and employers, ranging from individuals and sole proprietorships to large, multi-site and national employers and public sector employers, providing access to medical services for 29.7 million people as of December 31, 2025. UnitedHealthcare Medicare & Retirement delivers health and well-being benefits to seniors and other Medicare eligible consumers, serving 8.4 million people through its Medicare Advantage products and 10.4 million people in Medicare Part D programs as of December 31, 2025, and served 4.3 million seniors through various Medicare Supplement products. UnitedHealthcare Community & State serves consumers who are economically disadvantaged, the medically underserved and those without the benefit of employer sponsored health benefits coverage, participating in programs in 32 states and the District of Columbia and serving nearly 7.4 million people as of December 31, 2025. Premium revenues from CMS represented 44% of UnitedHealth Group's total consolidated revenues for the year ended December 31, 2025, most of which were generated by UnitedHealthcare Medicare & Retirement.

Optum operates three business segments which combine distinctive capabilities in value-based care, population health, health care operations, data and analytics and pharmacy care services. Optum Health delivers patient-centered care, care management, wellness and consumer engagement, and health financial services, providing comprehensive and patient-centered care to 95 million consumers and serving more than 100 health payer partners. Optum Health's offerings include fully accountable value-based arrangements, administrative fee arrangements, and fee-for-service arrangements. Optum Financial, including Optum Bank, serves consumers through nearly 26 million consumer accounts with more than $27 billion in assets under management as of December 31, 2025. Optum Insight offers data, analytics, research, consulting, technology and managed services solutions, connecting the health care system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient. Optum Insight's aggregate backlog as of December 31, 2025 was approximately $31.1 billion, of which $18.3 billion is expected to be realized within the next 12 months. Optum Rx provides diversified pharmacy care services through its network of approximately 64,000 retail pharmacies, through home delivery, specialty and community health pharmacies, the provision of in-home and community-based infusion services and through rare disease and gene therapy support services. In 2025, Optum Rx managed $188 billion in pharmaceutical spending, including nearly $87 billion in specialty pharmaceutical spending.

In the fourth quarter of 2025, the Company took various actions as a result of a strategic review of the Company's assets and businesses to operationally advance and scale core businesses and initiatives, including the value-based care business at Optum Health. These actions primarily include losses on business exits and dispositions and other businesses held for sale and a gain on the deconsolidation of a business. As a result of the Company's portfolio actions, the Company recorded a net gain of $568 million, which included a net gain of $1.5 billion at Optum Rx, partially offset by losses of $821 million and $68 million at Optum Health and Optum Insight, respectively. Additionally, in the fourth quarter of 2025 the Company took restructuring and other actions that resulted in a total impact of $2.5 billion, which included real estate rationalization and workforce reductions of $746 million, contractual reassessments of $573 million, the establishment a loss contract reserve related to anticipated future losses in 2026 for certain value-based care businesses of $623 million, net valuation losses on equity securities of $329 million and the advance funding of the United Health Foundation of $250 million. To support care providers impacted by the Change Healthcare cyberattack that occurred on February 21, 2024, the Company provided interest-free loans. In the fourth quarter of 2025, the Company increased its reserves for net collection expectations associated with provider loans and other customer balances of $799 million.

Consolidated revenues grew 12% to $447.567 billion ¹ in 2025 from $400.278 billion ² in 2024. Earnings from operations were $18.964 billion ³ compared to $32.287 billion ⁴ last year, impacted by elevated medical cost trend, restructuring and other actions, gains related to business portfolio refinement in 2024, partially offset by net portfolio divestitures in 2025 and decreased impacts related to the Change Healthcare cyberattack. Diluted earnings per common share was $13.23 ⁵. Cash flows from operations were $19.697 billion ⁶.

However, management discusses expectations for membership trends, noting that as a result of continued funding pressures, which have resulted in benefit and pricing actions, the company expects that its Medicare Advantage membership will contract in 2026. Additionally, due to increased pricing in response to anticipated care patterns in 2026 and decreased people served through UnitedHealthcare Medicare Advantage offerings, the company expects the number of people served under value-based care arrangements to contract. The company also expects Medicaid membership losses in 2026 as a result of reduced Medicaid eligibility and the exit from one state.

A key focus of future growth is to accelerate the transition from fee-for-service care delivery and payment models to fully accountable value-based care. This transition requires initial costs such as system enhancements, integrated care coordination technology, physician training and clinical engagement. The company continues to see a greater number of people enrolled in fully accountable value-based plans that reward high-quality, affordable care and foster collaboration. This trend is creating needs for health management services that can coordinate care around the primary care physician, including new primary care channels, and for investments in new clinical and administrative information and management systems, which the company believes provide growth opportunities for its Optum business platform.

The company is working to accelerate realization of benefits through the innovation and integration of its care delivery models, including in-clinic, in-home, behavioral and virtual care, and by using its data, analytics and AI to provide clinicians with the information necessary to provide the best possible care in the most cost-efficient setting. The company anticipates that fast-evolving AI technologies, including generative AI, will play an increasingly important role in its information systems and customer-facing technology products. The company also notes that it has elevated its audit, clinical policy and payment integrity tools to protect customers and patients from unnecessary costs.

The company discusses margin and cost trends in the context of medical cost trends and pricing. For 2025, the company's pricing trends and patient and member health status assumptions were well-short of the medical cost trends incurred, significantly impacting earnings. The company has observed increased care patterns that are above what it expected and contemplated in its pricing and benefits design, as well as an increase in health care unit costs and in the intensity of services delivered. The company endeavors to mitigate medical cost increases by engaging hospitals, physicians and consumers with information and helping them make clinically sound choices, with the objective of helping them achieve high-quality, affordable care. The company also notes that the Inflation Reduction Act (IRA) altered the Medicare Part D model and benefits, shifting more risk to plans, which results in both increased premiums and medical costs.

The company discusses its capital allocation priorities. In June 2025, the Board of Directors increased the Company's quarterly cash dividend to shareholders to an annual rate of $8.84 ⁷ compared to $8.40 per share ⁸, which the Company had paid since June 2024. As of December 31, 2025, the Company had 21 million shares ⁹ remaining available under its share repurchase authorization. Purchases of property, equipment and capitalized software were $3.622 billion ¹⁰ in 2025. The company also notes that it continually evaluates opportunities to expand its operations, which include internal development of new products, programs and technology applications and may include acquisitions.

The company identifies several headwinds and constraints. Medicare Advantage funding continues to be pressured, with the Advanced Notice for 2027 being far below the expected industry forward medical cost trend. Increased medical costs in 2025, which are expected to continue in future periods, have added to the compounding impact of the previous multi-year rate shortfalls creating sustained pressure on the Medicare Advantage program. Substantial revisions to the risk adjustment model have resulted and will continue to result in reduced funding and potentially benefits for people, especially those with some of the greatest health and social challenges. Due to elevated care activity in Medicaid, specifically related to behavioral, pharmacy and home health, there continues to be a timing mismatch between the health status of people served and state rate updates. The funding and payment rate environment remains insufficient to meet the health needs of patients and creates the risk of continued downward pressure on Medicaid margin percentages.

The company also notes that the commercial risk market remains highly competitive in the small group, large group and individual segments. Continued increased medical costs may impact both future pricing and benefit design, including for individual exchange products in markets where the company chooses to remain, and may result in shifts between product categories for employer benefits. These potential changes, along with certain regulatory impacts, may result in decreased membership in future periods.

The company faces significant risk from its ability to estimate, price for and manage medical costs, as premium revenues from risk-based products constitute nearly 80% of total consolidated revenues. Relatively small differences between predicted and actual medical costs have resulted and in the future may result in significant changes in financial results. The company is also subject to risks from cyberattacks and other privacy or data security incidents, having previously reported that its Change Healthcare business was subject to a cyberattack in 2024 in which the data involved contained protected health information or personally identifiable information. The company's business is highly regulated, and a reduction or less than expected increase in government funding for Medicare Advantage, Medicare Part D, or Medicaid programs could materially and adversely affect results; premium revenues from CMS represented 44% of total consolidated revenues for the year ended December 31, 2025. The company's goodwill and other intangible assets had a carrying value of $131 billion as of December 31, 2025, representing 42% of total consolidated assets, and any future impairment could materially and adversely affect results of operations and equity. The company also faces risks from its increasing use of AI, as to the extent an AI system does not operate as intended or produces an inaccurate, incomplete or biased output, the system could impact operations, customer service or other functions.

Management's message to shareholders emphasizes the company's mission to help people live healthier lives and help make the health system work better for everyone, and the two distinct, yet complementary businesses — Optum and UnitedHealthcare — working to help build a modern, high-performing health system. The tone acknowledges significant challenges, noting that for 2025, pricing trends and patient and member health status assumptions were well-short of the medical cost trends incurred, significantly impacting earnings. Management outlines strategic priorities including accelerating the transition from fee-for-service care delivery and payment models to fully accountable value-based care, and continuing to take a prudent, market-sustainable posture for both new business and maintenance of existing relationships in the Medicaid market. Management also emphasizes the company's commitment to advocating for actuarially sound rates commensurate with medical cost trends and remaining dedicated to partnering with those states that are committed to the long-term viability of their programs.